Lifastuzumab (Anti-SLC34A2)
Lifastuzumab (Anti-SLC34A2) is a monoclonal antibody targeting SLC34A2 (sodium phosphate 2 transporter(NaPi2b)). It has anticancer activity and can be used in research of ovarian cancer (OC).
Trivial name | NaPi3b |
Catalog Number | A3163 |
CAS# | 1615697-16-9 |
Size | 1mg*25 |